India's Sakar Healthcare jumps on oncology products' deal
** Shares of Sakar Healthcare SAKA.NS rise as much as 9.8%
before trimming some gains, last up 1.4% at 341.75 rupees
** Pharma products maker said its oncology unit has entered
into deal with seven overseas partners for supply of its
oncology products
** Stock eyes busiest trading day since early March, volumes
at 8.7x the 30-day avg
** Including session's gains, stock down ~15% so far this
year
(Reporting by Manvi Pant in Bengaluru)
((Manvi.Pant@thomsonreuters.com; +918447554364;))
Recent news on Sakar Healthcare
See all newsIndia's Sakar Healthcare jumps on regulatory approvals for cancer drugs
Brief: Sakar Healthcare Gets 14 Oncology Product New Approvals In EU, UK, Canada With 7 Business Partners
Brief: Sakar Healthcare Says Co Added To Manufacturing Of Accord's (UK) Finished Product Imatinib Accord
Australia's Algorae Pharmaceuticals rises on licensing deal with Sakar Healthcare
Brief: Algorae Pharmaceuticals Signs Exclusive License Agreement With Sakar